Clinical trial
A Phase 2, Two-Part, Multicenter Study of HTX-011 in Spinal Surgery
NCT04911062 is registered in ClinicalTrials.gov with Heron Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2, Two-Part, Multicenter Study of HTX-011 in Spinal Surgery
- Lead sponsor
- Heron Therapeutics
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 7, 2022
- Completion date
- August 26, 2022
- Enrollment
- 32 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.
lumbar laminectomy, post-operative pain